Navigation Links
Multisorb Technologies' Non-Toxic StabilOx Oxygen Absorbing Canisters Provide Worry-Free Drug Stability
Date:4/8/2013

BUFFALO, N.Y., April 8, 2013 /PRNewswire/ -- Recently, an uncharacteristic odor associated with a competitor's oxygen absorbing canister caused a  voluntary drug recall by a major pharmaceutical manufacturer.

Multisorb's non-toxic StabilOx® Oxygen Absorbing Canisters were not the cause nor were involved with this drug product recall.

Issues with substandard oxygen absorbers are a systemic issue in the industry. Though not the fault of the pharmaceutical manufacturers that closely adhere to regulatory requirements, recalls like this create a long-lasting, negative impact for the manufacturer as well as for the consumers that rely on the drug product.

For pharmaceutical manufacturers concerned about oxygen absorbers creating off odors and potentially contaminating their drug products, Multisorb Technologies continues to supply the pharmaceutical industry with its non-toxic StabilOx Oxygen Absorbing Canisters. StabilOx Canisters do not exhibit the unpleasant odor that initiated the recall.

StabilOx Oxygen Absorbing Canisters help resolve complex stability challenges without the use of toxic components. StabilOx Canisters are non-toxic and formaldehyde free.

Unlike the competing oxygen absorbing canister that offers only a minimum 20cc of oxygen capacity and thereby requires the supplemental use of expensive EVOH-based oxygen barrier bottles, Multisorb's StabilOx Canisters offer a minimum 100cc of oxygen capacity and can be used with standard HDPE bottles. Consequently, a container-closure system using StabilOx Canisters can cost 50% less than the competing canister/bottle system.

StabilOx Canisters reduce oxidative degradation of drug products and stabilize the pharmaceutical formulations by managing the package headspace moisture and drug product free-moisture.  When used within a foil-laminate heat induction sealed standard HDPE bottle, StabilOx Canisters will effectively reduce oxygen to levels below 1% while maintaining humidity levels to <30%, thereby preventing over-drying and balancing the drug product's chemical and physical stability profiles.

For added value, Multisorb's StabilOx System combines the protection of its StabilOx Canisters with the reliability of its APA-9000 StabilOx Canister Dispenser, offering an unparalleled system for reliability and ease. Multisorb's APA-9000 easily integrates into existing packaging lines and offers a variety of options.

As a long time supplier to the pharmaceutical industry, Multisorb has the answer for safe, non-toxic drug stability that you can count on. Call us today, we can help.

About Multisorb Technologies

Multisorb Technologies has been an innovator in active packaging technology for more than 50 years. Founded in 1961 by John S. Cullen to protect products against the damaging effects of moisture, today Multisorb is the world leader in the development and production of active packaging components.

Multisorb's corporate offices are located at 325 Harlem Road, Buffalo, New York 14224 USA. For more information contact: Phone: +1 716-824-8900; Fax: +1 716-824-4128; E-mail: info@multisorb.com; Website: www.multisorb.com.  


'/>"/>
SOURCE Multisorb Technologies
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Ajinomoto Co., Inc. Completes Acquisition of Althea Technologies, Inc.
2. Advances in Surgical Technologies Boost Demand for Efficient Bone Graft Substitutes, Finds Frost & Sullivan
3. Cantel Medicals Mar Cor Purification Subsidiary Acquires Hemodialysis Water Business from Siemens Water Technologies Business Unit
4. SafeCode Drug Technologies Initiating Activities to Commercialize its Recent Newly Acquired Technology of the Pain-Free Injection
5. Research and Markets Announces the Release of Autoimmune Disease Therapeutics to 2016. Targets, Technologies, Therapies, Markets and Opportunities
6. Palatin Technologies Announces Notification of Patent Allowance On Melanocortin Receptor-1 Specific Peptides
7. Patient Safety Technologies Reports Fourth Quarter And Fiscal 2012 Results
8. Medbox Acquires 50% of MedVend and its Patented Technologies
9. BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2012 Financial Results
10. SafeCode Drug Technologies Acquires Breakthrough Painless Injection Technology
11. Xyntek-Antares & ESS Technologies to Unveil New Ultra Compact TaskMate(R) Robotic Case Erector / Loader with Track & Trace at Interphex 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... PUNE, India , April 29, 2016 /PRNewswire/ ... - Pipeline Review, H1 2016" market research report ... pipeline, complete with comparative analysis at various stages, ... (MoA), route of administration (RoA) and molecule type, ... press releases. It also reviews key players involved ...
(Date:4/29/2016)... Glycotope GmbH, a clinical-stage immuno-oncology company built ... Dr. Alfredo Zurlo as Chief Medical Officer. ... years clinical experience and a proven track record in ... at Mologen AG where he was Chief Medical Officer ... held various positions at F Hoffmann La Roche and ...
(Date:4/28/2016)... NEW YORK , April 28, 2016 /PRNewswire/ ... will notably complement the company,s valve repair and ... the move also places Abbott more firmly into ... one of the fastest growing device areas, with ... to its recent report,  Advanced Remote Patient ...
Breaking Medicine Technology:
(Date:5/2/2016)... , ... May 02, 2016 , ... The 2016 World Ultimate & Guts Championship (WUGC) ... at Manhattan College, made the cut. The WUGC is being held in London, England this ... the gold in the men’s division, another gold in the women’s masters division, and a ...
(Date:5/2/2016)... ... , ... Pregnancy Awareness Month offers a great time to get familiar with ... are ready to have a baby, it’s best to get started before age becomes ... Personal Conception & Pregnancy Organizer, written for women who plan on becoming pregnant to ...
(Date:5/2/2016)... ... May 02, 2016 , ... A ... completed two groundbreaking studies that determined that the adjustability and adaptability of pediatric ... the prevention of pressure injuries, which are now referred to as “pressure injuries” ...
(Date:5/2/2016)... ... May 02, 2016 , ... Atlantic Information Services, Inc. (AIS) ... B Payment Model Could Transform the Pharma Landscape .” CMS recently proposed a test ... spend on provider-administered drugs while preserving care provided to beneficiaries. The webinar will review ...
(Date:5/2/2016)... ... May 02, 2016 , ... The Evolve Paddle Board Company- ... prices announced today the outcome of their partnership with Yoloha Yoga- producers of high ... Yoga Board.” , SUP yoga has seen a dramatic rise in popularity throughout the ...
Breaking Medicine News(10 mins):